GlassScriptPhysician profile
Shelly D Davis
NPI 1386805885
$4,288.47
in general payments reported to CMS, 2019-2025
34 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $591 · 2022: $618 · 2023: $859 · 2024: $1,008 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,079.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $830.06 | 2021-2025 | |
| Novo Nordisk INC | $460.80 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $399.94 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Dexcom, INC. | $294.50 | 2022-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $278.03 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $236.63 | 2021-2025 | |
| Amgen INC. | $231.84 | 2021-2025 | Repatha, Otezla, Prolia |
| Glaxosmithkline, LLC. | $225.43 | 2021-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Astellas Pharma US INC | $187.63 | 2021-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $167.87 | 2021-2023 | Spravato |
| Amarin Pharma, INC. | $156.32 | 2021-2022 | |
| Exact Sciences Corporation | $96.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $87.75 | 2023-2025 | Freestyle Libre 3, Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.34 | 2023-2024 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $61.78 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $47.16 | 2025 | Auvelity |
| Sumitomo Pharma America, INC. | $44.28 | 2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $43.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $43.72 | 2022 | |
| Corium, LLC | $41.41 | 2022 | |
| Idorsia Pharmaceuticals US INC | $33.75 | 2023 | Quviviq |
| Ibsa Pharma INC. | $30.65 | 2025 | Tirosint, Flector, Licart |
| Merck Sharp & Dohme LLC | $28.78 | 2021 | |
| Horizon Therapeutics Plc | $25.55 | 2021 | |
| Medtronic, INC. | $25.26 | 2025 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.57 | 2025 | |
| Lundbeck LLC | $20.44 | 2024 | Rexulti |
| Shield Therapeutics INC | $19.22 | 2024 | |
| Esperion Therapeutics, INC. | $17.89 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.68 | 2021 | |
| Sanofi Pasteur INC. | $14.11 | 2023 | |
| Eisai INC. | $13.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.39 | 2021 | |
| Genentech USA, INC. | $9.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.